We are live on ! Find out more
CDTX

Cidara Therapeutics

Delisted

CDTX was delisted on the 6th of January, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$21.9M -$2.78M -12,077 -12%
FM
2
Frazier Management
Washington
$16.7M
RCM
3
RA Capital Management
Massachusetts
$14.9M
AC
4
Aisling Capital
New York
$12.9M
BB
5
BB Biotech
Switzerland
$9.48M +$3.23M +14,007 +60%
PA
6
Perceptive Advisors
New York
$9.43M
Goldman Sachs
7
Goldman Sachs
New York
$3.49M -$3.12M -13,559 -50%
AIC
8
AWM Investment Company
New York
$3.37M +$1.33M +5,750 +77%
EAM
9
Eventide Asset Management
Massachusetts
$3.35M
RSCM
10
Rock Springs Capital Management
Maryland
$3.17M
BC
11
Broadfin Capital
New York
$2.12M
Vanguard Group
12
Vanguard Group
Pennsylvania
$2.06M +$319K +1,386 +21%
BFA
13
BlackRock Fund Advisors
California
$1.56M -$82.3K -357 -5%
PI
14
Putnam Investments
Massachusetts
$1.27M
TCM
15
Tekla Capital Management
Massachusetts
$921K +$230K +1,000 +38%
DM
16
Deerfield Management
New York
$873K -$584K -2,534 -42%
Northern Trust
17
Northern Trust
Illinois
$638K +$922 +4 +0.2%
SM
18
Sabby Management
Florida
$512K +$464K +2,014 New
UOC
19
UBS O'Connor
Illinois
$498K -$8.76K -38 -2%
State Street
20
State Street
Massachusetts
$475K +$40.3K +175 +10%
BIT
21
BlackRock Institutional Trust
California
$437K -$15.9K -69 -4%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$343K +$6.68K +29 +2%
BIM
23
BlackRock Investment Management
Delaware
$219K +$3.92K +17 +2%
NFA
24
Nationwide Fund Advisors
Ohio
$217K
Bank of New York Mellon
25
Bank of New York Mellon
New York
$208K +$922 +4 +0.5%